Urokinase receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 13: | Line 13: | ||
Elevated levels of soluble uPAR are associated with kidney disease<ref>PMID:26539835</ref>. uPAR which is expressed at high levels in malignant tutors is unattractive target for treatment of cancer<ref>PMID:35303878</ref>. uPAR activity in cancer cells may counteract the activity of anticancer drugs<ref>PMID:26283964</ref>. | Elevated levels of soluble uPAR are associated with kidney disease<ref>PMID:26539835</ref>. uPAR which is expressed at high levels in malignant tutors is unattractive target for treatment of cancer<ref>PMID:35303878</ref>. uPAR activity in cancer cells may counteract the activity of anticancer drugs<ref>PMID:26283964</ref>. | ||
==Structural highlights== | |||
==3D structures of urokinase receptor== | ==3D structures of urokinase receptor== |